Medical Assistance in Dying committee  Good evening. Thank you, Chair and committee members, for having us here today. My name is Kelly Masotti and I'm the vice-president of advocacy, and with me today is Daniel Nowoselski, advocacy manager, hospice palliative care. Before I begin my remarks, I would like to acknow

Health committee  I will do my best to answer quickly. We're very concerned by the dramatic increase in youth vaping, and there needs to be comprehensive government response. For example, the draft regulation on flavours and e-cigarettes should be adopted as soon as possible and, indeed, the pro

Health committee  I'll start this, Helena, and then you can add. I think what's most important is to continue to place an emphasis on the importance of screening and diagnoses. We have seen a shift to virtual care in some instances, so it would be to continue to encourage parents to take their ch

Health committee  I can start with that. We want cancer patients to have access to the best treatment in the location of their choice, so any additional funding from the federal government to support innovation, to support drugs and technology that will eventually help cancer patients in the loca

Health committee  I'm happy to jump in here to start. Thank you for the question. Oh, go ahead. I'm sorry about that.

Health committee  Yes. Thanks for that question. We are entirely supportive of the front-of-package labelling, and we thank the government for implementing this and moving it along. We would also echo the comments of the previous witness to encourage the government to implement all factors of the

Health committee  Thanks, Helena, that was great. Yes, I just have two points as it relates to later-stage diagnoses. If we miss that, then that can be harder to treat, as well as costing the system more.

Health committee  Thank you, Chair. Thank you for your patience. I also really appreciate the support from House of Commons IT staff. Good morning. Thank you, Chair and committee members, for having me here today. My name is Kelly Masotti. I'm vice-president of advocacy. Here with me today is Hel

Health committee  Thank you for your question. The Canadian Cancer Society pays close attention to the supports that are available for caregivers, as well as for people living with cancer. We are focusing our attention now on the need to increase the employment insurance sickness benefit. I'd li

Health committee  Thank you, Stuart. I want to acknowledge I am joining virtually from Ottawa, which is the unceded territory of the Algonquin Anishinabe Nation. The COVID-19 pandemic has also shown us that substantial gaps persist in accessing palliative care, particularly at home or in the co

Finance committee  Thank you for the question. We were supportive of at least 26 weeks, which is what has been included in the federal budget. We were pleased to see that as a starting point. We know that claimants exhaust the 15-week mark that currently exists. About three-quarters of claimants

Finance committee  It's nice to see you again as well. I think I'm going to get back to you with a more detailed response. I was prepared to speak to EI today and the tobacco tax increase. What I will say is that any increase to research dollars in Canada is a bonus. What we saw with COVID and th

Finance committee  I sure can. Thank you very much for the question. This change is critical for people who are living with cancer. As I stated in my opening remarks, cancer in certain instances can actually be looked upon as a chronic disease—not in every case, but in some—and people are interes

Finance committee  Yes, Mr. Easter.

Finance committee  Thank you, Mr. Chair and members of Parliament. On behalf of the Canadian Cancer Society, thank you for the opportunity to appear before the committee today. My name is Kelly Masotti. I'm the vice-president of advocacy. With me is Rob Cunningham, senior policy analyst, and Ste